Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
NCT07670130
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia (AML)
Sponsor
The First Affiliated Hospital of Soochow University